Reported Earlier, Pulse Biosciences Highlights nPulse Cardiac Catheter Ablation Study Achieving Durable AF Treatment Outcomes With Average Procedure Time Of 65 Minutes And Low SAE Rate

Pulse Biosciences, Inc. -2.37%

Pulse Biosciences, Inc.

PLSE

18.14

-2.37%

Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via